Literature DB >> 15075094

Restricted use of Vlambda genes in POEMS syndrome.

Soubrier Martin1, Pierre Labauge, Pierre Jouanel, Jean Louis Viallard, Jean Charles Piette, Bernard Sauvezie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15075094

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  5 in total

Review 1.  Amyloidosis and POEMS syndrome.

Authors:  Cheng E Chee; Angela Dispenzieri; Morie A Gertz
Journal:  Expert Opin Pharmacother       Date:  2010-06       Impact factor: 3.889

2.  Immunoglobulin variable domain high-throughput sequencing reveals specific novel mutational patterns in POEMS syndrome.

Authors:  Sébastien Bender; Vincent Javaugue; Alexis Saintamand; Maria Victoria Ayala; Mehdi Alizadeh; Matthieu Filloux; Virginie Pascal; Nathalie Gachard; David Lavergne; Fabienne Auroy; Michel Cogné; Frank Bridoux; Christophe Sirac; Arnaud Jaccard
Journal:  Blood       Date:  2020-05-14       Impact factor: 22.113

3.  POEMS Syndrome: Clinical and Laboratory Approach Towards Diagnosis.

Authors:  Mala Mahto; Tarun Kumar; Mukunda Kumar; Gunjan Kumar; Sushil Kumar; Akash Bansal; Ayan Banerjee
Journal:  Indian J Clin Biochem       Date:  2021-01-03

4.  Mass cytometry identifies expansion of double positive and exhausted T cell subsets in the tumour microenvironment of patients with POEMS syndrome.

Authors:  Taxiarchis V Kourelis; Dragan Jevremovic; Erik Jessen; Surendra Dasari; Jose C Villasboas; Angela Dispenzieri; Shaji Kumar
Journal:  Br J Haematol       Date:  2020-02-20       Impact factor: 6.998

5.  Characteristics of 1946 Cases of POEMS Syndrome in Chinese Subjects: A Literature-Based Study.

Authors:  Yong Wang; Li-Bo Huang; Yi-Hua Shi; Huan Fu; Zhen Xu; Guo-Qing Zheng; Yan Wang
Journal:  Front Immunol       Date:  2019-06-21       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.